Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands

Details for Australian Patent Application No. 2004209540 (hide)

Owner AstraZeneca AB NPS Pharmaceuticals, Inc.

Inventors Wensbro, David; Raboisson, Patrick; Nordvall, Gunnar; Minidis, Alexander; Johansson, Martin; Gyback, Helena

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004209540

PCT Pub. Number WO2004/069813

Priority 60/530,632 19.12.03 US; 60/443,889 31.01.03 US

Filing date 26 January 2004

Wipo publication date 19 August 2004

International Classifications

C07D 241/44 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 491/04 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 031/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 025/00 Drugs for disorders of the nervous system

C07D 241/00 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 311/00 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07F 007/18 Compounds containing elements of the 4th Group of the Periodic System

C07C 237/04 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 031/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

C07D 241/52 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 241/38 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/069813 Priority application(s): WO2004/069813

13 December 2007 Assignment before Grant

  AstraZeneca AB; NPS Pharmaceuticals, Inc. The application has been assigned to AstraZeneca AB

20 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004209545-Razor head having skin controlling means

2004209539-Method and device for mounting the shaft equipment